Predictors of adverse outcome from candidal infection in a tertiary care hospital

被引:25
作者
Ben-Abraham, R
Keller, N
Teodorovitch, N
Barzilai, A
Harel, R
Barzilay, Z
Paret, G [1 ]
机构
[1] Chaim Sheba Med Ctr, Sackler Fac Med, Dept Pediat Intens Care, IL-52621 Tel Hashomer, Israel
[2] Tel Aviv Univ, Sackler Fac Med, Sourasky Med Ctr, Dept Anesthesiol & Crit Care, Tel Aviv, Israel
[3] Tel Aviv Univ, Dept Clin Microbiol, Tel Aviv, Israel
[4] Chaim Sheba Med Ctr, Sackler Fac Med, Dept Pediat Infect Dis, IL-52621 Tel Hashomer, Israel
关键词
candida; infection; outcome;
D O I
10.1016/j.jinf.2004.02.015
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives. To retrospectively delineate predictors of adverse outcome by looking at the demographic features, therapy and outcome of systemic candida infection in a large tertiary care university-affiliated medical center. Methods. We reviewed the clinical data on 186 inpatients with candidemia over a 6 year period. The major reason for their hospital admission was an underlying malignancy or an infection other than candidemia. Results. Candida albicans, tropicalis, parapsilosis, glabrata and krusei caused 54, 22, 13, 8 and 3% of the candidemia episodes, respectively. The overall mortality was 42% and it was highest in patients suffering from candidemia of the glabrata species (73%). Forty-eight (63%) of the 76 patients who received no anti-fungal treatment died compared to 38 (34%) of 110 patients who were treated (P < 0.05). Predictors of adverse outcome were intensive care unit stay, renal failure, thrombocytopenia and the need for mechanical ventilation or inotropic support. Conclusions. We identified four predictors of mortality from candidemia infection. Their validity should be further assessed and the specific candida strains and their susceptibility need to be methodically identified. Our data support immediate initiation of therapy at first identification of infection. (C) 2004 The British Infection Society. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:317 / 323
页数:7
相关论文
共 30 条
  • [1] Candiduria in critically ill patients admitted to intensive care medical units
    Alvarez-Lerma, F
    Nolla-Salas, J
    León, C
    Palomar, M
    Jordá, R
    Carrasco, N
    Bobillo, F
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (07) : 1069 - 1076
  • [2] Predictors of adverse outcome in cancer patients with candidemia
    Anaissie, EJ
    Rex, JH
    Uzun, Ö
    Vartivarian, S
    [J]. AMERICAN JOURNAL OF MEDICINE, 1998, 104 (03) : 238 - 245
  • [3] Bion J, 1994, New Horiz, V2, P341
  • [4] Risk factors for candidal bloodstream infections in surgical intensive care unit patients: The NEMIS Prospective Multicenter Study
    Blumberg, HM
    Jarvis, WR
    Soucie, JM
    Edwards, JE
    Patterson, JE
    Pfaller, MA
    Rangel-Frausto, MS
    Rinaldi, MG
    Saiman, L
    Wiblin, RT
    Wenzel, RP
    [J]. CLINICAL INFECTIOUS DISEASES, 2001, 33 (02) : 177 - 186
  • [5] Bodey Gerald P., 1993, P279
  • [6] Systemic fungal infections in patients with hematologic malignancies:: Indications and limitations of the antifungal armamentarium
    Böhme, A
    Karthaus, M
    [J]. CHEMOTHERAPY, 1999, 45 (05) : 315 - 324
  • [7] Candidemia in critically ill patients: difference of outcome between medical and surgical patients
    Charles, PE
    Doise, JM
    Quenot, JP
    Aube, H
    Dalle, F
    Chavanet, P
    Milesi, N
    Aho, LS
    Portier, H
    Blettery, B
    [J]. INTENSIVE CARE MEDICINE, 2003, 29 (12) : 2162 - 2169
  • [8] de Marie S, 2000, HAEMATOLOGICA, V85, P88
  • [9] De Pauw BE, 1998, SUPPORT CARE CANCER, V6, P31
  • [10] Epidemiology of candidemia: 3-year results from the emerging infections and the epidemiology of Iowa organisms study
    Diekema, DJ
    Messer, SA
    Brueggemann, AB
    Coffman, SL
    Doern, GV
    Herwaldt, LA
    Pfaller, MA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 2002, 40 (04) : 1298 - 1302